Published in Curr Opin Virol on July 06, 2012
Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas. J Infect (2012) 1.52
Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. PLoS One (2013) 0.89
Fanconi anemia patients are more susceptible to infection with tumor virus SV40. PLoS One (2013) 0.83
Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters. PLoS Pathog (2014) 0.83
Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. Diabetes (2015) 0.82
Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy. PLoS One (2014) 0.78
Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects. PLoS One (2016) 0.77
Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples from patients affected by uveal melanoma. J Hematol Oncol (2014) 0.76
Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein. Front Immunol (2017) 0.75
THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN. Proc Natl Acad Sci U S A (1964) 5.88
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (2000) 5.44
Seroepidemiology of human polyomaviruses. PLoS Pathog (2009) 4.62
Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (1999) 3.20
Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis (1985) 2.64
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst (2003) 2.07
Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77
Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol (2001) 1.69
Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica (2005) 1.53
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res (2005) 1.29
Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg (2002) 1.29
Detection of human-derived fecal pollution in environmental waters by use of a PCR-based human polyomavirus assay. Appl Environ Microbiol (2006) 1.28
Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis (2005) 1.25
Detection of BK, JC, WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples. J Clin Virol (2009) 1.24
Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology (2004) 1.21
Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol (2012) 1.19
Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses. Eur J Epidemiol (1991) 1.15
Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors. Hum Immunol (2012) 1.13
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J Med Virol (2009) 1.11
Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med (1962) 1.06
Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol (2009) 1.03
Newly described human polyomaviruses Merkel cell, KI and WU are present in urban sewage and may represent potential environmental contaminants. Virol J (2010) 0.99
Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev Med Virol (2004) 0.91
Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol (2009) 0.90
High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant (2008) 0.89
Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma. Pathol Int (2007) 0.88
First decade (1950-1960) of studies and trials with the polio vaccine. Biologicals (2006) 0.87
Evaluating sewage-associated JCV and BKV polyomaviruses for sourcing human fecal pollution in a coastal river in Southeast Queensland, Australia. J Environ Qual (2010) 0.87
Epidemiologic studies of polyomaviruses and cancer: previous findings, methodologic challenges and future directions. Adv Exp Med Biol (2006) 0.86
SV40 in adenovirus vaccines and adenovirus-SV40 recombinants. Dev Biol Stand (1998) 0.77
Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int J Cancer (2003) 0.77